DK0951553T3 - Adenovirus-E4-proteiner til induktion af celledød - Google Patents
Adenovirus-E4-proteiner til induktion af celledødInfo
- Publication number
- DK0951553T3 DK0951553T3 DK97935709T DK97935709T DK0951553T3 DK 0951553 T3 DK0951553 T3 DK 0951553T3 DK 97935709 T DK97935709 T DK 97935709T DK 97935709 T DK97935709 T DK 97935709T DK 0951553 T3 DK0951553 T3 DK 0951553T3
- Authority
- DK
- Denmark
- Prior art keywords
- adenovirus
- analog
- biologically active
- active fragment
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2127396P | 1996-07-05 | 1996-07-05 | |
US2874096P | 1996-10-22 | 1996-10-22 | |
PCT/IB1997/001041 WO1998001563A2 (en) | 1996-07-05 | 1997-07-03 | Adenovirus e4 proteins for inducing cell death |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0951553T3 true DK0951553T3 (da) | 2004-02-09 |
Family
ID=26694498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97935709T DK0951553T3 (da) | 1996-07-05 | 1997-07-03 | Adenovirus-E4-proteiner til induktion af celledød |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0951553B1 (da) |
JP (1) | JP2000515504A (da) |
AT (1) | ATE253117T1 (da) |
AU (1) | AU731924B2 (da) |
CA (1) | CA2259152C (da) |
DE (1) | DE69725882T2 (da) |
DK (1) | DK0951553T3 (da) |
ES (1) | ES2208942T3 (da) |
PT (1) | PT951553E (da) |
WO (1) | WO1998001563A2 (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003523722A (ja) | 1999-03-01 | 2003-08-12 | セル ジェネシス インコーポレイテッド | 抗新生物性組成物およびその使用 |
EP1196773A1 (en) * | 1999-07-12 | 2002-04-17 | McGILL UNIVERSITY | E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death |
US7094529B2 (en) | 2000-02-22 | 2006-08-22 | Smithkline Beecham Corporation | Bunyaviridal reaper proteins and uses therefore |
ES2218395T3 (es) * | 2000-02-22 | 2004-11-16 | Glaxo Group Limited | Proteinas virales de muerte celular y usos de las mismas. |
US7635676B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaccuticals, Inc. | Modified annexin proteins and methods for their use in organ transplantation |
ES2286247T3 (es) | 2001-02-21 | 2007-12-01 | Alavita Pharmaceuticals, Inc. | Proteinas anexinicas modificacdas y tratamiento de la trombosis. |
US7635680B2 (en) | 2001-02-21 | 2009-12-22 | Alavita Pharmaceuticals, Inc. | Attenuation of reperfusion injury |
US7645739B2 (en) | 2001-02-21 | 2010-01-12 | Alavita Pharmaceuticals, Inc. | Modified annexin compositions and methods of using same |
FR2827866B1 (fr) | 2001-07-27 | 2004-12-10 | Pasteur Institut | Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations |
EP1327688A1 (en) * | 2002-01-14 | 2003-07-16 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Adenoviruses with enhanced lytic potency |
ES2335657T3 (es) * | 2002-04-25 | 2010-03-31 | Crucell Holland B.V. | Medios y metodos para la produccion de vectores de adenovirus. |
WO2003099859A2 (de) | 2002-05-27 | 2003-12-04 | Per Sonne Holm | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren |
CA2408207A1 (fr) * | 2002-10-16 | 2004-04-16 | Institut Pasteur | Peptides liant la proteine phosphatase 2a et polynucleotides les codant |
WO2005051430A1 (de) | 2003-11-14 | 2005-06-09 | Per Sonne Holm | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren |
CA3104948A1 (en) * | 2018-06-25 | 2020-01-02 | Ospedale San Raffaele S.R.L | Gene therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2726285B1 (fr) * | 1994-10-28 | 1996-11-29 | Centre Nat Rech Scient | Adenovirus depourvus de particules contaminantes viables, preparation et utilisation |
US5872005A (en) * | 1994-11-03 | 1999-02-16 | Cell Genesys Inc. | Packaging cell lines for adeno-associated viral vectors |
IL116816A (en) * | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
US6281010B1 (en) * | 1995-06-05 | 2001-08-28 | The Trustees Of The University Of Pennsylvania | Adenovirus gene therapy vehicle and cell line |
-
1997
- 1997-07-03 AU AU38601/97A patent/AU731924B2/en not_active Ceased
- 1997-07-03 ES ES97935709T patent/ES2208942T3/es not_active Expired - Lifetime
- 1997-07-03 DE DE69725882T patent/DE69725882T2/de not_active Expired - Fee Related
- 1997-07-03 CA CA002259152A patent/CA2259152C/en not_active Expired - Fee Related
- 1997-07-03 AT AT97935709T patent/ATE253117T1/de not_active IP Right Cessation
- 1997-07-03 DK DK97935709T patent/DK0951553T3/da active
- 1997-07-03 WO PCT/IB1997/001041 patent/WO1998001563A2/en active IP Right Grant
- 1997-07-03 PT PT97935709T patent/PT951553E/pt unknown
- 1997-07-03 JP JP10504995A patent/JP2000515504A/ja not_active Ceased
- 1997-07-03 EP EP97935709A patent/EP0951553B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU3860197A (en) | 1998-02-02 |
DE69725882T2 (de) | 2004-07-29 |
WO1998001563A3 (en) | 1998-03-12 |
AU731924B2 (en) | 2001-04-05 |
CA2259152A1 (en) | 1998-01-15 |
WO1998001563A2 (en) | 1998-01-15 |
EP0951553B1 (en) | 2003-10-29 |
JP2000515504A (ja) | 2000-11-21 |
CA2259152C (en) | 2002-02-12 |
EP0951553A2 (en) | 1999-10-27 |
DE69725882D1 (de) | 2003-12-04 |
ES2208942T3 (es) | 2004-06-16 |
PT951553E (pt) | 2004-02-27 |
ATE253117T1 (de) | 2003-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0951553T3 (da) | Adenovirus-E4-proteiner til induktion af celledød | |
BR0315688A (pt) | Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas | |
TR200001203T2 (tr) | Yeni birleşik maddeler | |
IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
DE59905954D1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
ES2196640T3 (es) | Dispositivo terapeutico transdermico con capsaicina y analogos de capsaicina. | |
EA199900494A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
ATE198050T1 (de) | Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia | |
DE69509544D1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
DE69530403D1 (de) | Analogen des keratinozytenwachstumfaktors | |
EE9900036A (et) | Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks | |
IT1299175B1 (it) | Composizione contenente radioisotopi immobilizzati su particelle solide, utile in particolare per la brachiterapia clinica in patologie | |
ATE55695T1 (de) | Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien. | |
DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
ATE230609T1 (de) | Verfahren zur behandlung von entzündungen und zusammensetzungen dafür | |
NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
DE69939075D1 (de) | Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten | |
FI801228A (fi) | 6-substituerade 11-alkylen-morfantridiner foerfaranden foer deras framstaellning och terapeutiska medel innehaollande dessa | |
DE69314586D1 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
ATE238796T1 (de) | Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten | |
DE3374066D1 (en) | N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor | |
DE3883044D1 (de) | Wirkstoff zur tumorbekaempfung. | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
DE3769497D1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. |